Pharmacokinetics of Cotadutide in Participants with Hepatic Impairment

Trial Identifier: D5671C00008
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05517226
Start Date: September 2022
Primary Completion Date: February 2023
Study Completion Date: February 2023
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
US (Spanish)

Trial Locations

Country Location
US, CA Rialto, CA, US, 92377
US, FL Hialeah, FL, US, 33014
US, OH Canton, OH, US, 44718
US, TX San Antonio, TX, US, 78215
US, TX San Antonio, TX, US, 78229